Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 2Phase 1 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 24Neoplasms 15Prostatic Neoplasms 12Lung Neoplasms 11Uterine Cervical Neoplasms 8Squamous Cell Carcinoma of Head and Neck 6Pancreatic Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Head and Neck Neoplasms 5Stomach Neoplasms 4Rectal Neoplasms 4Carcinoma, Squamous Cell 4Carcinoma, Basal Cell 4Uterine Cervical Dysplasia 3Skin Neoplasms 3Melanoma 3Glioma 3Glioblastoma 3Esophageal Neoplasms 3Disease 3Colorectal Neoplasms 3Central Nervous System Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Breast Neoplasms, Male 3Breast Carcinoma In Situ 3Barrett Esophagus 3Thyroid Neoplasms 2Sarcoma 2Precancerous Conditions 2Oligodendroglioma 2

Interventions

Magnetic Resonance Spectroscopy 4Therapeutics 3Immunoenzyme Techniques 3Early Intervention, Educational 3Cyclophosphamide 3Biopsy 3saponin QA-21V1 2exemestane 2Vorinostat 2Standard of Care 2Psychiatric Rehabilitation 2Physical Therapy Modalities 2Letrozole 2Immunologic Techniques 2Gene Expression Profiling 2Fluorodeoxyglucose F18 2Flow Cytometry 2Doxorubicin 2Docetaxel 2Chemotherapy, Adjuvant 2Bevacizumab 2Anastrozole 2Acupuncture Therapy 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2pegfilgrastim 1iso-sulfan blue 1alovudine 1Zoledronic Acid 1Trastuzumab 1Tomography, Emission-Computed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Breast Neoplasms, Male × Biopsy × Clear all
NCT01153672 2019-09-06

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy

University of Washington

Phase NA Completed
8 enrolled 10 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT02480933 2017-11-28

SISYPHUS

Centro Hospitalar Lisboa Ocidental

Phase NA Unknown
768 enrolled
Breast

Breast Neoplasms, Male

NCT00363012 2017-04-05

Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2

University of Washington

Phase NA Completed
56 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡